Matthew Lehman, CEO of Prima BioMed Ltd., “Developing Personalized Immunocellular Therapeutics for Ovarian Cancer”

On June 11, 2013 By

Mike Ghias and David Evans, Ph.D., CEO & CSO of General Research Laboratory (GRL), Inc., “Developing Technologies to Serve Biopharmaceutical Industry”

On April 16, 2013 By

Dr. Andreas Voigt, Chief Scientist TheraKine Ltd., “Drug Delivery Technology for Biologics and Small Molecules”

On March 20, 2013 By

Holland Johnson, Executive Editor MedicalDeviceDaily.com, “Trends in Medical Technology: Bioabsorbable Stents”

On March 8, 2013 By

Susan Windham-Bannister, Ph.D., President & CEO Massachusetts Life Sciences Center, “Investing in Life Sciences Research & Economic Development in Massachusetts”

On February 25, 2013 By

Dayan Goodenowe, Ph.D., President & CEO Phenomenome Discoveries, “COLOGIC – Blood Test that Screens for Colorectal Cancer”

On February 21, 2013 By

Michael Griffin, CFO University General Health System, Inc., “Acute Healthcare Provider in the Texas Region”

On February 13, 2013 By

Michael Oliver, President & CEO SpectraScience, “Biophotonics: the Intersection of Light-Based Technologies & Human Biology”

On February 8, 2013 By

Robert Schmidt, Chairman Flocel Inc., “Developing In Vitro Blood-Brain Barrier Technology for Researchers to Conduct In Vitro Studies”

On February 1, 2013 By

Thomas Moore, Chairman & CEO Advaxis, Inc. “Update on Clinical Trial for Cervical Cancer”

On January 29, 2013 By